tiprankstipranks
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
US Market

Acrivon Therapeutics, Inc. (ACRV) Income Statement

Compare
167 Followers

Acrivon Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), Acrivon Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Acrivon Therapeutics, Inc.'s net income was $-22.44M. See Acrivon Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -536.00K$ -1.09M$ -832.00K$ -13.00K
Operating Expenses
$ 66.70M$ 32.66M$ 16.18M$ 3.17M
Depreciation and Amortization
$ 536.00K$ 1.09M$ 832.00K$ 13.00K
EBITDA
$ -59.85M$ -30.07M$ -15.41M$ -5.29M
Operating Income
$ -67.24M$ -32.66M$ -16.18M$ -3.17M
Other Income/Expenses
$ 6.85M$ 1.49M$ -59.00K$ -2.14M
Pretax Income
$ -60.39M$ -31.17M$ -16.24M$ -5.31M
Net Income
$ -60.39M$ -29.68M$ -16.24M$ -5.31M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -2.74$ -1.35$ -0.78$ -0.25
Diluted EPS
$ -2.74$ -1.35$ -0.78$ -0.25
Weighted Average Shares Outstanding
22.08M 21.92M 20.86M 20.86M
Weighted Average Shares Outstanding (Diluted)
22.08M 21.92M 20.86M 20.86M
Currency in USD

Acrivon Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis